Executive Summary
Astrazeneca sued Emcure Pharmaceuticals Limited and MSN Laboratories Limited for infringing their patents related to the pharmaceutical compound TICAGRELOR, marketed as BRILINTA. The plaintiffs sought an interim injunction against the defendants' generic versions (TICAPLAT and TIARE).
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Astrazeneca Ab vs Emcure Pharmaceuticals Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Db Corp LtdvsWhatsapp Llc & Ors
Db Corp Ltd filed a suit against WhatsApp LLC alleging unauthorized circulation of its copyrighted e-newspapers within private messaging groups. The Delhi High Court granted an interim ex-parte injunction, directing WhatsApp to immediately take down and block the identified infringing groups. This order underscores the platform's responsibility in preventing copyright infringement when content is illegally shared on its services.
Pharmacyclics Llc & Anr.vsShilpa Medicare Limited & Anr.
This judgment addresses a batch of six infringement suits filed by Pharmacyclics LLC and its affiliates against various pharmaceutical companies, including Shilpa Medicare Limited. The core dispute revolves around the alleged unauthorized manufacturing and marketing of Ibrutinib, a drug protected by Indian Patent 262968 (IN'968). The court granted interim restraint orders preventing the defendants from further manufacturing or marketing the drug pending the final disposal of the suits.
Curewin Pharmaceuticals Pvt. Ltd.vsRegistrar Of Trademarks Govt. Of India
The Madhya Pradesh High Court granted an interim measure in the trademark opposition case filed by Curewin Pharmaceuticals Pvt. Ltd. against the Registrar of Trademarks, Government of India. The court directed that no further proceedings related to the specific publication date (11.08.2025) shall be taken until the next hearing date. This temporary stay provides crucial breathing room for the petitioner while procedural requirements are met.
Samridhi EnterprisesvsFlipkart Internet Private Limited & Ors.
Samridhi Enterprises filed a suit against Flipkart and several sellers for alleged infringement of its trade marks and copyrighted marketing materials related to car covers. The court recognized the prima facie case of infringement, particularly concerning the unauthorized use of design look-and-feel and promotional imagery by third-party sellers on the platform. Crucially, the court issued an interim injunction restraining these infringing parties from using the plaintiff's intellectual property until the full trial can proceed.
Quikr India Private LimitedvsSellquikr Private Limited
The Karnataka High Court disposed of the writ petition based on a joint compromise memo between Quikr India Private Limited and Sellquikr Private Limited. The core agreement stipulated that Sellquikr acknowledged having no rights over Quikr's registered trademarks and copyrighted material. Furthermore, Sellquikr committed to immediately changing its corporate name by removing 'QUIKR,' taking down all associated websites and applications, transferring the domain name sellquikr.in/ to Quikr, and ceasing any use of Quikr's intellectual property.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.